Amir Hadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Amir Hadi has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Ehsan Ghaedi
Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
16 shared publications - Arman Arab
Division of Sleep Medicine, Harvard Medical School, Boston, MA, USA; Medical Chronobiology Program, Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, MA, USA
15 shared publications - Makan Pourmasoumi
Department of Food and Human Nutritional Sciences, Faculty of Agriculture and Food Sciences University of Manitoba Winnipeg Manitoba Canada
15 shared publications Abed Ghavami
Student Research Committee, Department of Clinical Nutrition, School of Nutrition and Food Science Isfahan University of Medical Sciences Isfahan Iran
12 shared publications- Gholamreza Askari
Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
12 shared publications Ameneh Najafgholizadeh
Department of Microbiology, Naein Branch, Islamic Azad University, Isfahan, Iran
8 shared publications
Latest Publications
- 31 October 2023
- Published by Wiley in Phytotherapy Research
- Vol. 38 (2) , 520-526
Propolis as an adjunctive therapy for treatment of uncomplicated cystitis in women: A randomized double‐blind placebo‐controlled trial
The current research is designed to investigate the effect of propolis supplementation on the clinical manifestations in women suffering from uncomplicated cystitis. In this randomized double‐blind, placebo‐controlled trial, 120 women with uncomplicated cystitis were selected and randomly assigned into two groups to receive two 500 mg capsules of propolis or placebo daily for 7 days along with ciprofloxacin (250 mg). Clinical symptoms including hematuria, urinary frequency, dysuria, suprapubic pain, and urgency, as well as bacteriuria, were assessed before and after the intervention. After supplementation, participants in the intervention group had significantly fewer days of urinary frequency (p < 0.001), dysuria (p = 0.005), and urgency (p = 0.03). However, there was no significant difference between the two groups regarding hematuria and suprapubic pain (p > 0.05). Furthermore, the severity of bacteriuria decreased significantly in both groups. In conclusion, it seems that propolis supplementation in women with uncomplicated cystitis could improve urinary frequency, dysuria, and urgency. However, further clinical trials should be conducted to fully understand the effects of propolis in women suffering from uncomplicated cystitis.
- 31 October 2023
- Published by Wiley in Phytotherapy Research
- Vol. 38 (2) , 520-526
Propolis as an adjunctive therapy for treatment of uncomplicated cystitis in women: A randomized double‐blind placebo‐controlled trial
The current research is designed to investigate the effect of propolis supplementation on the clinical manifestations in women suffering from uncomplicated cystitis. In this randomized double‐blind, placebo‐controlled trial, 120 women with uncomplicated cystitis were selected and randomly assigned into two groups to receive two 500 mg capsules of propolis or placebo daily for 7 days along with ciprofloxacin (250 mg). Clinical symptoms including hematuria, urinary frequency, dysuria, suprapubic pain, and urgency, as well as bacteriuria, were assessed before and after the intervention. After supplementation, participants in the intervention group had significantly fewer days of urinary frequency (p < 0.001), dysuria (p = 0.005), and urgency (p = 0.03). However, there was no significant difference between the two groups regarding hematuria and suprapubic pain (p > 0.05). Furthermore, the severity of bacteriuria decreased significantly in both groups. In conclusion, it seems that propolis supplementation in women with uncomplicated cystitis could improve urinary frequency, dysuria, and urgency. However, further clinical trials should be conducted to fully understand the effects of propolis in women suffering from uncomplicated cystitis.
- 5 August 2023
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 27 (7) , 677-687
Associations between diet quality and migraine headaches: a cross-sectional study
AimsWe evaluated associations between diet quality and migraine outcomes.MethodsThe current work represented a cross-sectional study on 262 patients with migraine (20-50 y). Diet quality was assessed using the standard healthy eating index 2015 (HEI-2015) and alternative healthy eating index 2010 (AHEI-2010). A validated 168-item food frequency questionnaire was used to assess dietary intake. Migraine outcomes included clinical factors (severity, duration, frequency, and disability related to migraine) and serum nitric oxide (NO). Associations between diet quality indices and migraine outcomes were evaluated using linear regressions, and & beta; and 95% corresponding confidence interval (CI) were reported.ResultsHEI-2015 was inversely associated with migraine frequency (& beta; = -4.75, 95% CI: -6.73, -2.76) in patients with the highest HEI scores (third tertile) vs. those with the lowest scores (first tertile) after adjusting for relevant confounders. AHEI-2010 was inversely associated with migraine frequency (& beta; = -3.67, 95% CI: -5.65, -1.69) and migraine-related disability (& beta; = -2.74, 95% CI: -4.79, -0.68) in adjusted models. Also, AHEI-2010 was inversely associated with migraine severity in patients in the second vs. first tertile (& beta; = -0.56; 95% CI: -1.08, -0.05). We detected no associations between diet quality and NO levels (All P > 0.14).ConclusionsImproved diet quality may be associated with favorable migraine outcomes (lower headache frequency, severity, and migraine-related disability). Future studies are required to confirm and delineate the causal mechanisms of our observations.
- 5 August 2023
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 27 (7) , 677-687
Associations between diet quality and migraine headaches: a cross-sectional study
AimsWe evaluated associations between diet quality and migraine outcomes.MethodsThe current work represented a cross-sectional study on 262 patients with migraine (20-50 y). Diet quality was assessed using the standard healthy eating index 2015 (HEI-2015) and alternative healthy eating index 2010 (AHEI-2010). A validated 168-item food frequency questionnaire was used to assess dietary intake. Migraine outcomes included clinical factors (severity, duration, frequency, and disability related to migraine) and serum nitric oxide (NO). Associations between diet quality indices and migraine outcomes were evaluated using linear regressions, and & beta; and 95% corresponding confidence interval (CI) were reported.ResultsHEI-2015 was inversely associated with migraine frequency (& beta; = -4.75, 95% CI: -6.73, -2.76) in patients with the highest HEI scores (third tertile) vs. those with the lowest scores (first tertile) after adjusting for relevant confounders. AHEI-2010 was inversely associated with migraine frequency (& beta; = -3.67, 95% CI: -5.65, -1.69) and migraine-related disability (& beta; = -2.74, 95% CI: -4.79, -0.68) in adjusted models. Also, AHEI-2010 was inversely associated with migraine severity in patients in the second vs. first tertile (& beta; = -0.56; 95% CI: -1.08, -0.05). We detected no associations between diet quality and NO levels (All P > 0.14).ConclusionsImproved diet quality may be associated with favorable migraine outcomes (lower headache frequency, severity, and migraine-related disability). Future studies are required to confirm and delineate the causal mechanisms of our observations.
- Open Access
- 4 January 2023
- Published by Wiley in Food Science & Nutrition
- Vol. 11 (4) , 1622-1633
The effect of a low versus high sodium diet on blood pressure in diabetic patients: A systematic review and meta‐analysis of clinical trials
There have been numerous clinical trials that have investigated the effect of sodium intake on blood pressure in diabetic patients. The purpose of this systematic review and meta‐analysis was to evaluate the clinical trial studies performed on the effect of low sodium diet (LSD) versus high sodium diet (HSD) on blood pressure in diabetic patients. PubMed, Scopus, and Web of Science were systematically searched from database inception to July 10, 2021. Both type 1 and 2 diabetes was considered. Overall, there were 15 studies included in this meta‐analysis. The weighted (WMD) mean difference with 95% confidence interval (CI) was calculated using a random‐effects model. Risk of bias in the studies was assessed based on the Cochrane collaboration tool and the quality of all the studies was considered as good. Overall, LSD significantly reduced SBP (systolic blood pressure) (WMD: −3.79 mmHg, 95% CI: −6.02, −1.56) and DBP (diastolic blood pressure) (WMD: −1.62 mmHg, 95% CI: −2.84, −0.40), in comparison with HSD, in diabetics. However, LSD had no significant effect on MAP (mean arterial pressure) in comparison with HSD (WMD: −1.81, 95%CI: −5.49, 1.87). Although subgroup analysis could not attenuate heterogeneity in SBP, subgroup analysis in DBP based on duration (≤1 week: WMD: −2.35, 95%CI: −3.69, −1.00, I2 = 48.9%, p = 0.081, >1 week: WMD: −1.04, 95% CI: −2.83, 0.76, I2 = 74.7%, p = 0.003) and study design (cross‐over: WMD: −1.94, 95% CI: −2.71, −1.17, I2 = 32.1%, p = 0.183, parallel: WMD: −2.17, 95% CI: −6.48, 2.13, I2 = 82.4%, p = 0.001) successfully detected sources of heterogeneity. LSD significantly reduced SBP and DBP, however, had no effect on MAP, in comparison with HSD.
- 4 January 2023
- Published by Wiley in Food Science & Nutrition
- Vol. 11 (4) , 1622-1633
Open AccessThe effect of a low versus high sodium diet on blood pressure in diabetic patients: A systematic review and meta‐analysis of clinical trials
There have been numerous clinical trials that have investigated the effect of sodium intake on blood pressure in diabetic patients. The purpose of this systematic review and meta‐analysis was to evaluate the clinical trial studies performed on the effect of low sodium diet (LSD) versus high sodium diet (HSD) on blood pressure in diabetic patients. PubMed, Scopus, and Web of Science were systematically searched from database inception to July 10, 2021. Both type 1 and 2 diabetes was considered. Overall, there were 15 studies included in this meta‐analysis. The weighted (WMD) mean difference with 95% confidence interval (CI) was calculated using a random‐effects model. Risk of bias in the studies was assessed based on the Cochrane collaboration tool and the quality of all the studies was considered as good. Overall, LSD significantly reduced SBP (systolic blood pressure) (WMD: −3.79 mmHg, 95% CI: −6.02, −1.56) and DBP (diastolic blood pressure) (WMD: −1.62 mmHg, 95% CI: −2.84, −0.40), in comparison with HSD, in diabetics. However, LSD had no significant effect on MAP (mean arterial pressure) in comparison with HSD (WMD: −1.81, 95%CI: −5.49, 1.87). Although subgroup analysis could not attenuate heterogeneity in SBP, subgroup analysis in DBP based on duration (≤1 week: WMD: −2.35, 95%CI: −3.69, −1.00, I2 = 48.9%, p = 0.081, >1 week: WMD: −1.04, 95% CI: −2.83, 0.76, I2 = 74.7%, p = 0.003) and study design (cross‐over: WMD: −1.94, 95% CI: −2.71, −1.17, I2 = 32.1%, p = 0.183, parallel: WMD: −2.17, 95% CI: −6.48, 2.13, I2 = 82.4%, p = 0.001) successfully detected sources of heterogeneity. LSD significantly reduced SBP and DBP, however, had no effect on MAP, in comparison with HSD.
- 29 December 2022
- Published by Wiley in Phytotherapy Research
- Vol. 37 (2) , 388-398
The effect of saffron (Crocus sativus L.) on glycemia, lipid profile, and antioxidant status in patients with type‐2 diabetes mellitus: A randomized placebo‐controlled trial
In the current study, we aimed to investigate the effect of saffron supplementation on glycemic status, lipid profile, atherogenic indices, and oxidative status in patients with type‐2 diabetes (T2DM). In a randomized, double‐blind controlled trial, 70 patients were randomly allocated into two groups (n = 35, each) and received 100 mg/day of saffron or placebo for eight weeks. Dietary intake, weight, body mass index (BMI), waist and hip circumferences (WC and HC), waist to hip ratio (WHR), fasting blood sugar (FBS), hemoglobin A1c (HbA1c), insulin, and Homeostatic model assessment for insulin resistance (HOMA‐IR), lipid profile, atherogenic indices, oxidative status, and liver enzymes were determined before and after the intervention. At the end of the eighth week, saffron intervention could significantly reduce FBS (7.57%), lipid profile (except high‐density lipoprotein cholesterol [HDL‐C]), atherogenic indices, and liver enzymes (p < .05). Moreover, saffron could improve oxidative status (nitric oxide [NO] and malondialdehyde [MDA] reduced by 26.29% and 16.35%, respectively). Catalase (CAT) concentration remained unchanged. Saffron supplementation may alleviate T2DM by improving glycemic status, lipid profile, liver enzymes, and oxidative status. Further investigation is necessary to assess possible side effects and confirm the positive effect of saffron as a complementary therapy in clinical recommendations for T2DM.
- 29 December 2022
- Published by Wiley in Phytotherapy Research
- Vol. 37 (2) , 388-398
The effect of saffron (Crocus sativus L.) on glycemia, lipid profile, and antioxidant status in patients with type‐2 diabetes mellitus: A randomized placebo‐controlled trial
In the current study, we aimed to investigate the effect of saffron supplementation on glycemic status, lipid profile, atherogenic indices, and oxidative status in patients with type‐2 diabetes (T2DM). In a randomized, double‐blind controlled trial, 70 patients were randomly allocated into two groups (n = 35, each) and received 100 mg/day of saffron or placebo for eight weeks. Dietary intake, weight, body mass index (BMI), waist and hip circumferences (WC and HC), waist to hip ratio (WHR), fasting blood sugar (FBS), hemoglobin A1c (HbA1c), insulin, and Homeostatic model assessment for insulin resistance (HOMA‐IR), lipid profile, atherogenic indices, oxidative status, and liver enzymes were determined before and after the intervention. At the end of the eighth week, saffron intervention could significantly reduce FBS (7.57%), lipid profile (except high‐density lipoprotein cholesterol [HDL‐C]), atherogenic indices, and liver enzymes (p < .05). Moreover, saffron could improve oxidative status (nitric oxide [NO] and malondialdehyde [MDA] reduced by 26.29% and 16.35%, respectively). Catalase (CAT) concentration remained unchanged. Saffron supplementation may alleviate T2DM by improving glycemic status, lipid profile, liver enzymes, and oxidative status. Further investigation is necessary to assess possible side effects and confirm the positive effect of saffron as a complementary therapy in clinical recommendations for T2DM.
- 22 December 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (1) , 199-204
Effects of eicosapentaenoic acid supplementation on heat shock protein 27, glycemic status and anthropometric indices in type 2 diabetes patients
Purpose Heat shock proteins (HSP-27) are reported to be involved in the pathophysiology of diabetes complications. The purpose of the current study is to assess the effects of eicosapentaenoic acid (EPA) supplementation on serum HSP-27, glycemic status and anthropometric indices in type 2 diabetes mellitus (T2DM) patients. Methods Thirty-six patients with T2DM were randomly allocated to obtain 2 g per day EPA (n = 18) or placebo (n = 18) for 8 weeks in a randomized, double-blind, placebo-controlled clinical trial. Fasting serum levels of HSP 27, fasting blood sugar, hemoglobin A1C, as well as anthropometric indices were measured. Results EPA supplementation reduces the serum level of HSP 27 in the EPA group compared with the placebo (P < 0.03). Although waist circumference (WC) decreased significantly in the EPA group at the end of the trial (P < 0.02), there was no significant difference in weight, WC, body mass index (BMI), and glycemic markers in both groups after intervention (P > 0.05). Conclusions We found that EPA supplementation reduces HSP 27 serum level in T2DM patients. However, future large-scale trials are needed.
- 22 December 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (1) , 199-204
Effects of eicosapentaenoic acid supplementation on heat shock protein 27, glycemic status and anthropometric indices in type 2 diabetes patients
Purpose Heat shock proteins (HSP-27) are reported to be involved in the pathophysiology of diabetes complications. The purpose of the current study is to assess the effects of eicosapentaenoic acid (EPA) supplementation on serum HSP-27, glycemic status and anthropometric indices in type 2 diabetes mellitus (T2DM) patients. Methods Thirty-six patients with T2DM were randomly allocated to obtain 2 g per day EPA (n = 18) or placebo (n = 18) for 8 weeks in a randomized, double-blind, placebo-controlled clinical trial. Fasting serum levels of HSP 27, fasting blood sugar, hemoglobin A1C, as well as anthropometric indices were measured. Results EPA supplementation reduces the serum level of HSP 27 in the EPA group compared with the placebo (P < 0.03). Although waist circumference (WC) decreased significantly in the EPA group at the end of the trial (P < 0.02), there was no significant difference in weight, WC, body mass index (BMI), and glycemic markers in both groups after intervention (P > 0.05). Conclusions We found that EPA supplementation reduces HSP 27 serum level in T2DM patients. However, future large-scale trials are needed.
- Open Access
- 29 August 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 9622546
The Effect of Saffron (Crocus sativus L.) Supplementation on Renal Function: A Systematic Review and Meta‐Analysis of Randomized Controlled Clinical Trials
Background. The present systematic review and meta‐analysis of randomized controlled trials (RCTs) aimed at determining the effect of saffron supplementation on renal function. Methods. Electronic databases were searched up to February 2021. The risk of bias in individual studies was assessed using the Cochrane Collaboration tool. The overall weighted mean difference (WMD) and their 95% confidence intervals (CIs) were calculated using random‐effect models. P < 0.05 was considered statistically significant. Results. A total of 11 trials were included in this study. Saffron had beneficial effect on BUN (WMD = −0.69 mg/dl; 95% CI, −1.36 to −0.01; P = 0.046) compared to placebo, with significant heterogeneity (I2 = 49.6%, P = 0.037). However, it had no significant effect on serum Cr (WMD = 0.04 mg/dl; 95% CI: −0.01 to 0.09; P = 0.127). Conclusion. It seems that saffron supplementation had no significant effect on Cr as a renal function factor. However, BUN reduction was significant in the saffron group compared to placebo.
- 29 August 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 9622546
Open AccessThe Effect of Saffron (Crocus sativus L.) Supplementation on Renal Function: A Systematic Review and Meta‐Analysis of Randomized Controlled Clinical Trials
Background. The present systematic review and meta‐analysis of randomized controlled trials (RCTs) aimed at determining the effect of saffron supplementation on renal function. Methods. Electronic databases were searched up to February 2021. The risk of bias in individual studies was assessed using the Cochrane Collaboration tool. The overall weighted mean difference (WMD) and their 95% confidence intervals (CIs) were calculated using random‐effect models. P < 0.05 was considered statistically significant. Results. A total of 11 trials were included in this study. Saffron had beneficial effect on BUN (WMD = −0.69 mg/dl; 95% CI, −1.36 to −0.01; P = 0.046) compared to placebo, with significant heterogeneity (I2 = 49.6%, P = 0.037). However, it had no significant effect on serum Cr (WMD = 0.04 mg/dl; 95% CI: −0.01 to 0.09; P = 0.127). Conclusion. It seems that saffron supplementation had no significant effect on Cr as a renal function factor. However, BUN reduction was significant in the saffron group compared to placebo.
- 17 August 2022
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 64 (4) , 943-956
The effect of nigella supplementation on blood pressure: A systematic review and dose-response meta-analysis
This study was performed to assess the effect of nigella supplementation on blood pressure levels among the adult population. A comprehensive search was carried out through PubMed, Scopus, Web of Science, and Cochrane Library by using relevant keywords to find out the randomized clinical trials evaluating the effect of nigella administration on systolic blood pressure (SBP) and diastolic blood pressure (DBP). A random-effect model was applied to achieve the overall effect size. Subgroup analysis and meta-regression were used to explore the source of heterogeneity and the effects of the possible moderators. Of the twenty-two trials that were eligible for the present study, seventeen studies consisting of 1048 participants were included in the meta-analysis. The results indicated that nigella administration could significantly reduce both SBP (−4.58 mmHg; 95%CI: −6.22, −2.94) and DBP (−3.08 mmHg; 95%CI: −4.62, −1.55). Subgroup analysis did not show any superiority between subgroups of variables. Dose-response analysis detected a nonlinear association between dose and duration of administration and change in blood pressure outcomes, highlighting that maximum SBP and DBP reduction was experienced at 2000 mg/day and 8 weeks of nigella administration, respectively. The present study suggests that nigella supplementation can be beneficial for managing blood pressure.
- 17 August 2022
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 64 (4) , 943-956
The effect of nigella supplementation on blood pressure: A systematic review and dose-response meta-analysis
This study was performed to assess the effect of nigella supplementation on blood pressure levels among the adult population. A comprehensive search was carried out through PubMed, Scopus, Web of Science, and Cochrane Library by using relevant keywords to find out the randomized clinical trials evaluating the effect of nigella administration on systolic blood pressure (SBP) and diastolic blood pressure (DBP). A random-effect model was applied to achieve the overall effect size. Subgroup analysis and meta-regression were used to explore the source of heterogeneity and the effects of the possible moderators. Of the twenty-two trials that were eligible for the present study, seventeen studies consisting of 1048 participants were included in the meta-analysis. The results indicated that nigella administration could significantly reduce both SBP (−4.58 mmHg; 95%CI: −6.22, −2.94) and DBP (−3.08 mmHg; 95%CI: −4.62, −1.55). Subgroup analysis did not show any superiority between subgroups of variables. Dose-response analysis detected a nonlinear association between dose and duration of administration and change in blood pressure outcomes, highlighting that maximum SBP and DBP reduction was experienced at 2000 mg/day and 8 weeks of nigella administration, respectively. The present study suggests that nigella supplementation can be beneficial for managing blood pressure.
- 7 July 2022
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 129 (10) , 1693-1702
Effects of pistachios on glycaemic control: a systematic review and meta-analysis of randomised controlled trials
To evaluate the effects of pistachio consumption on the glucoregulatory status in individuals with a high risk of cardiovascular disease (CVD), a systematic review and meta-analysis of randomized controlled trials (RCT) was conducted. Online databases including PubMed, Scopus, Web of Science, and Cochrane Library were searched from inception until June 2019. Human trials that reported data for fasting blood sugar (FBS), fasting insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) were included. Data were pooled using the random effect models and expressed as weighted mean difference (WMD) with 95% confidence interval (CI). Eight RCT were included in the analyses. Pistachio consumption, exchanged isocalorically for other foods, decreased FBS (WMD: -5.32 mg/dL, 95% CI: -7.80 to -2.64, P < 0.001), and insulin (WMD: -1.86 µIU/mL, 95% CI: -3.13 to -0.59, P < 0.01) concentrations in individuals with a high risk of cardiovascular disease. However, no changes were observed in the levels of HOMA-IR between the groups (WMD: -0.66, 95% CI: -1.89 to 0.58, P = 0.30). Pistachio consumption may improve glucoregulatory status in individuals at risk for CVD, as evidenced by reduced FBS and insulin concentrations. However, due to the limited availability of studies with diabetic cases and relatively small sample sizes of available studies, well-designed trials with adequate sample sizes aimed at diabetic populations are recommended.
- 7 July 2022
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 129 (10) , 1693-1702
Effects of pistachios on glycaemic control: a systematic review and meta-analysis of randomised controlled trials
To evaluate the effects of pistachio consumption on the glucoregulatory status in individuals with a high risk of cardiovascular disease (CVD), a systematic review and meta-analysis of randomized controlled trials (RCT) was conducted. Online databases including PubMed, Scopus, Web of Science, and Cochrane Library were searched from inception until June 2019. Human trials that reported data for fasting blood sugar (FBS), fasting insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) were included. Data were pooled using the random effect models and expressed as weighted mean difference (WMD) with 95% confidence interval (CI). Eight RCT were included in the analyses. Pistachio consumption, exchanged isocalorically for other foods, decreased FBS (WMD: -5.32 mg/dL, 95% CI: -7.80 to -2.64, P < 0.001), and insulin (WMD: -1.86 µIU/mL, 95% CI: -3.13 to -0.59, P < 0.01) concentrations in individuals with a high risk of cardiovascular disease. However, no changes were observed in the levels of HOMA-IR between the groups (WMD: -0.66, 95% CI: -1.89 to 0.58, P = 0.30). Pistachio consumption may improve glucoregulatory status in individuals at risk for CVD, as evidenced by reduced FBS and insulin concentrations. However, due to the limited availability of studies with diabetic cases and relatively small sample sizes of available studies, well-designed trials with adequate sample sizes aimed at diabetic populations are recommended.
- Open Access
- 4 April 2022
- Published by Springer Nature in BMC Nutrition
- Vol. 8 (1) , 1-12
Empirically derived dietary patterns and their association with mental health: a cross-sectional sample of Iranian migraine patients (2019–2020)
Objectives: Based on a comprehensive search, we realized that there is no previous study conducted among migraine patients to assess the association between major dietary patterns and mental health. Therefore, the present study aims to explore the relationship between empirically-derived dietary patterns and depression, anxiety, and stress in a sample of Iranian migraine patients. Methods: A total of 262 migraine patients (20–50 years) were selected through simple random sampling method for this study. Dietary intake during the previous year was determined using a validated 168-item, semi-quantitative food frequency questionnaire (FFQ), and major dietary patterns were derived using principal component analysis (PCA). For mental health evaluation, authors used the Depression, Anxiety, and Stress Scales (DASS- 21) questionnaire. Statistical analysis included multinomial logistic regression analysis and results were expressed as odds ratio (OR) with a 95% confidence interval (CI). Results: We identified three major dietary patterns including “traditional”, “western”, and “healthy”. After controlling for potential confounders, those in the highest tertile of the healthy dietary pattern had lower odds of depression (OR = 0.44, 95% CI: 0.22, 0.88; P for trend: 0.030) and stress (OR = 0.50, 95% CI: 0.25, 0.99; P for trend: 0.049). However, no significant association was observed between western and traditional dietary patterns and mental disorders. Conclusions: In summary, significant associations were documented between healthy dietary patterns and risk of depression and stress. Current findings urge migraine patients to increase their intakes of fruits, vegetables, eggs, whole grains, nuts and seeds, meat, and poultry and reduce the intake of fast foods and snacks, processed meat, fish, cola drink, condiments, dairy, and vegetable pickles to diminish the chance of depression and stress.
- 4 April 2022
- Published by Springer Nature in BMC Nutrition
- Vol. 8 (1) , 1-12
Open AccessEmpirically derived dietary patterns and their association with mental health: a cross-sectional sample of Iranian migraine patients (2019–2020)
Objectives: Based on a comprehensive search, we realized that there is no previous study conducted among migraine patients to assess the association between major dietary patterns and mental health. Therefore, the present study aims to explore the relationship between empirically-derived dietary patterns and depression, anxiety, and stress in a sample of Iranian migraine patients. Methods: A total of 262 migraine patients (20–50 years) were selected through simple random sampling method for this study. Dietary intake during the previous year was determined using a validated 168-item, semi-quantitative food frequency questionnaire (FFQ), and major dietary patterns were derived using principal component analysis (PCA). For mental health evaluation, authors used the Depression, Anxiety, and Stress Scales (DASS- 21) questionnaire. Statistical analysis included multinomial logistic regression analysis and results were expressed as odds ratio (OR) with a 95% confidence interval (CI). Results: We identified three major dietary patterns including “traditional”, “western”, and “healthy”. After controlling for potential confounders, those in the highest tertile of the healthy dietary pattern had lower odds of depression (OR = 0.44, 95% CI: 0.22, 0.88; P for trend: 0.030) and stress (OR = 0.50, 95% CI: 0.25, 0.99; P for trend: 0.049). However, no significant association was observed between western and traditional dietary patterns and mental disorders. Conclusions: In summary, significant associations were documented between healthy dietary patterns and risk of depression and stress. Current findings urge migraine patients to increase their intakes of fruits, vegetables, eggs, whole grains, nuts and seeds, meat, and poultry and reduce the intake of fast foods and snacks, processed meat, fish, cola drink, condiments, dairy, and vegetable pickles to diminish the chance of depression and stress.